These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19096000)

  • 21. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
    Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
    Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor.
    Herkert O; Kuhl H; Sandow J; Busse R; Schini-Kerth VB
    Circulation; 2001 Dec; 104(23):2826-31. PubMed ID: 11733402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
    Mirkin S; Wong BC; Archer DF
    Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.
    Hyder SM; Chiappetta C; Stancel GM
    Int J Cancer; 2001 May; 92(4):469-73. PubMed ID: 11304678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progestins, progesterone receptor modulators, and progesterone antagonists change VEGF release of endometrial cells in culture.
    Classen-Linke I; Alfer J; Krusche CA; Chwalisz K; Rath W; Beier HM
    Steroids; 2000; 65(10-11):763-71. PubMed ID: 11108887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.
    Courtin A; Communal L; Vilasco M; Cimino D; Mourra N; de Bortoli M; Taverna D; Faussat AM; Chaouat M; Forgez P; Gompel A
    Breast Cancer Res Treat; 2012 Jan; 131(1):49-63. PubMed ID: 21336598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets.
    Fleming I; Schulz C; Fichtlscherer B; Kemp BE; Fisslthaler B; Busse R
    Thromb Haemost; 2003 Nov; 90(5):863-71. PubMed ID: 14597982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells.
    Mirkin S; Wong BC; Archer DF
    Int J Gynecol Cancer; 2006; 16 Suppl 2():560-3. PubMed ID: 17010073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dehydroepiandrosterone prevents the aggregation of platelets obtained from postmenopausal women with type 2 diabetes mellitus through the activation of the PKC/eNOS/NO pathway.
    Muñoz YC; Gomez GI; Moreno M; Solis CL; Valladares LE; Velarde V
    Horm Metab Res; 2012 Jul; 44(8):625-31. PubMed ID: 22517552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro characterization of trimegestone: a new potent and selective progestin.
    Zhang Z; Lundeen SG; Zhu Y; Carver JM; Winneker RC
    Steroids; 2000; 65(10-11):637-43. PubMed ID: 11108870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levonorgestrel antagonism on estrogen-induced pituitary tumors is mediated by progesterone receptors.
    Rey-Roldán EB; Grillo CA; Pietranera L; Libertun C; Nicola AF; Piroli GG
    Horm Metab Res; 2008 Apr; 40(4):245-50. PubMed ID: 18548383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels.
    Yemisci M; Ay H; Kocaefe C; Qui J; Topalkara K; Ozgüç M; Kirazli S; Ozcebe O; Moskowitz MA; Dalkara T
    Cerebrovasc Dis; 2008; 26(2):190-8. PubMed ID: 18628618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential regulation of endothelium behavior by progesterone and medroxyprogesterone acetate.
    Cutini PH; Campelo AE; Massheimer VL
    J Endocrinol; 2014 Mar; 220(3):179-93. PubMed ID: 24301615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
    Lamberts SW; van Koetsveld P; Verleun T
    Cancer Res; 1987 Jul; 47(14):3667-71. PubMed ID: 3594432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agonist-Dependent Downregulation of Progesterone Receptors in Human Cervical Stromal Fibroblasts.
    Ackerman WE; Summerfield TL; Mesiano S; Schatz F; Lockwood CJ; Kniss DA
    Reprod Sci; 2016 Jan; 23(1):112-23. PubMed ID: 26243545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progestogens reduce thromboxane production by cultured human endothelial cells.
    Oviedo PJ; Sobrino A; Novella S; Rius C; Laguna-Fernandez A; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
    Climacteric; 2011 Feb; 14(1):41-8. PubMed ID: 20443717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of betamethasone (BM) on endothelial nitric oxide synthase (eNOS) expression in adult baboon femoral arterial endothelial cells.
    Aida K; Shi Q; Wang J; VandeBerg JL; McDonald T; Nathanielsz P; Wang XL
    J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):219-24. PubMed ID: 15336699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells.
    Archer DF; Navarro FJ; Leslie S; Mirkin S
    Fertil Steril; 2004 Jan; 81(1):165-70. PubMed ID: 14711561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression.
    Schatz F; Papp C; Aigner S; Krikun G; Hausknecht V; Lockwood CJ
    J Clin Endocrinol Metab; 1997 Jan; 82(1):188-93. PubMed ID: 8989257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.